Abstract
The definition of biologic has persistently being updated with the marketing of new product derived from engineered living resources. However, in broader sense biologic can be defined as any therapeutic complex biomolecule manufactured in, extracted from, or semi-synthesized from genetically engineered biological sources. Types of biologic drugs include vaccines, blood, blood components, cells, allergens, somatic cells, tissues, and recombinant proteins. The ward biologic is often referred as biopharmaceutical. Biologics can be composed of sugars, proteins, nucleic acids, or complex combinations of these substances. The host cells for biologics include microbes, insects, animal cells, mammalian cells, and plant cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anné J, Maldonado B, Van Impe J, Van Mellaert L, Bernaerts K (2012) Recombinant protein production and streptomycetes. J Biotechnol 158:159–167
Arakawa T, Yu J, Chong DKX, Hough J, Engen PC, Langridge WHR (1998) A plant – based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nat Biotechnol 16:934–938
Azam A, Li C, Metcalf KJ, Tullman-Ercek D (2015) Type III secretion as a generalizable strategy for the production of full-length biopolymer-forming proteins. Biotechnol Bioeng 113:2313–2320
Baneyx F (1999) Recombinant protein expression in Escherichia coli. Curr Opin Biotechnol 10:411–421
Baneyx F (2004) Protein expression technologies: current status and future trends. Taylor & Francis, New York
Boyhan D, Daniell H (2011) Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide. Plant Biotechnol J 9:585–598
Cameron DE, Bashor CJ, Collins JJ (2014) A brief history of synthetic biology. Nat Rev 12:381–390
Costa TRD, Felisberto-Rodrigues C, Meir A, Prevost MS, Redzej A, Trokter M et al (2015) Secretion systems in Gram-negative bacteria: structural and mechanistic insights. Nat Rev Microbiol 13:343–359. https://doi.org/10.1038/nrmicro3456
Fang C-Y, Wu C-C, Fang C-L, Chen W-Y, Chen C-L (2017) Long-term growth comparison studies of FBS and FBS alternatives in six head and neck cell lines. PLoS ONE 1(6):e0178960. https://doi.org/10.1371/journal.pone.0178960
Gaydhane MK, Mahanta U, Sharma CS, Khandelwal M, Ramakrishna S (2018) Cultured meat: state of the art and future. Biomanuf Rev 3:1. https://doi.org/10.1007/s40898-018-0005-1
Griffin TJ, Seth G, Xie H, Bandhakavi S, Hu WS (2007) Advancing mammalian cell culture engineering using genome-scale technologies. Trends Biotechnol 25(9):401–408
Hartley JL (2012) Why proteins in mammalian cells? Methods Mol Biol 801:1–12
Hatada Y, Hidaka Y, Nogi Y, Uchimura K, Katayama K, Li Z et al (2004) Hyper-production of an isomalto-dextranase of an Arthrobacter sp by a proteases-deficient Bacillus subtilis: sequencing, properties, and crystallization of the recombinant enzyme. Appl Microbiol Biotechnol 65:583–592
Huang M, Bao J, Nielsen J (2014) Biopharmaceutical protein production by Saccharomyces cerevisiae: current state and future prospects. Pharm Bioprocess 2:167–182
IntechOpen. (n.d.) Culture conditions and types of growth media for mammalian cells. IntechOpen. https://www.intechopen.com/books/biomedical-tissue-culture/culture-conditions-and-types-of-growth-media-for-mammalian-cells
Jozala AF, Geraldes DC, Tundisi LL, de Feitosa VA, Breyer CA, Cardoso SL, Mazzola PG, de Oliveira-Nascimento L, de Rangel-Yagui CO, de Magalhães PO et al (2016) Biopharmaceuticals from microorganisms: from production to purification. Braz J Microbiol 47:51–63
Kang Z, Yang S, Du G, Chen J (2014) Molecular engineering of secretory machinery components for high-level secretion of proteins in Bacillus species. J Ind Microbiol Biotechnol 41:1599–1607
Lee JS, Park HJ, Kim YH, Lee GM (2010) Protein reference mapping of dihydrofolatereductase-deficient CHO DG44 cell lines using 2-dimensional electrophoresis. Proteomics 10(12):2292–2302
Natale P, Brüser T, Driessen AJM (2008) Sec- and Tat-mediated protein secretion across the bacterial cytoplasmic membrane–distinct translocases and mechanisms. Biochem Biophys Acta 1778:1735–1756
Nettleship JE, Assenberg R, Diprose JM, Rahman-Huq N, Owens RJ (2010) Recent advances in the production of proteins in insect and mammalian cells for structural biology. J Struct Biol 172(1):55–65
Nielsen J (2013) Production of biopharmaceutical proteins by yeast: advances through metabolic engineering. Bioengineered 4:207–211
Nykiforuk CL, Boothe JG, Murray EW, Keon RG, Goren HJ, Markley NA, Moloney MM (2006) Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. Plant Biotechnol J 4:77–85
Öztürk S, Ḉalık P, Özdamar TH (2016a) Fed-batch biomolecule production by Bacillus subtilis: a state-of-the-art review. Trends Biotechnol 34:329–345
Öztürk S, Ḉalık P, Özdamar TH (2016b) Fed-batch biomolecule production by Bacillus subtilis: a state-of-the-art review. Trends Biotechnol 34:329–345
Park S, Schumann W (2015) Optimization of the secretion pathway for heterologous proteins in Bacillus subtilis. Biotechnol Bioprocess Eng 20:623–633
Persistence Market Research (2017) Serum-free media market: global industry trend analysis 2012 to 2017 and forecast 2017-2025. https://www.persistencemarketresearch.com/market-research/serum-free-media-market.asp
Pichia Produced Products (2018) Available online http://www.pichia.com/science-center/commercialized-products/. Accessed 3 February 2018
Reed B, Chen R (2013a) Biotechnological applications of bacterial protein secretion: from therapeutics to biofuel production. Res Microbiol 164:675–682
Reed B, Chen R (2013b) Biotechnological applications of bacterial protein secretion: from therapeutics to biofuel production. Res Microbiol 164:675–682
Rosano GL, Ceccarelli EA (2014) Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol 5:172
Wang A, Lu SD, Mark DF (1984) Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. Science 224:1431–1433
Westers L, Westers H, Quax WJ (2004) Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism. Biochem Biophys Acta 1694:299–310
World Health Organization (1992) Annex 1 (WHO Technical Report Series, No. 822). http://www.who.int/biologicals/publications/trs/areas/vaccines/gmp/WHO_TRS_822_A1.pdf?ua=1. Accessed 8 November 2015
Wurm FM, Hacker D (2011) First CHO genome. Nat Biotechnol 29(8):718–720
Yanagita M, Nakayama K, Takeuchi T (1992) Processing of mutated proinsulin with tetrabasic cleavage sites to bioactive insulin in the non-endocrine cell line, COS-7. FEBS Lett 311:55–59
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Behera, B.K., Prasad, R., Behera, S. (2020). Management and Manufacturing Process of Biologics. In: Competitive Strategies in Life Sciences. New Paradigms of Living Systems, vol 1. Springer, Singapore. https://doi.org/10.1007/978-981-15-7590-7_2
Download citation
DOI: https://doi.org/10.1007/978-981-15-7590-7_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-7589-1
Online ISBN: 978-981-15-7590-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)